Table 1. Comparison of the sensitivity of the CTC cluster assay and conventional CTC expansion techniques. N.D., not determined.
Cancer type |
Samples validated |
Duration | Culture type |
Pre- enrichment |
Efficiency in culture |
Correlation to treatment |
Reference |
Breast | 36 | >6 months | Cell lines, long-term | Yes | 16.70% | N.D. | (8) |
Breast | 8 | <1 month or ≧1 month |
Colonies (short-term) or cell lines (long-term) |
Yes | 37.50% | N.D. | (7) |
Colon | 71 | >2 months | Cell lines, long-term | Yes | 2.80% | N.D. | (52) |
Prostate | 17 | >6 months | Organoid lines, long-term | Yes | ~15–20% | N.D. | (9) |
Breast | 73 | 2 weeks | Primary CTC cluster (short- term) |
No | 19.6–59.3% (depending on treatment time point) |
Yes | This work |